INFLANET: Training European Experts in Inflammation: from the molecular players to animal models and the bedside
INFLANET is an EU Horizon 2020 Marie Skłodowska-Curie European Training Network that addresses the challenges of alleviating the societal burden of inflammation, not only for acute inflammatory disease, but also for multiple chronic diseases where inflammation is a major contributing factor. In Europe, direct healthcare costs incurred by such patients can be of several billion € per year. Chronic inflammation also plays significant roles in other diseases and conditions that lead to chronic pain, poor sleep quality, obesity, physical impairment, and overall decreased quality of life.
It is critical that Europe trains its own scientists to meet these challenges.
The aim of this ETN is to provide the recruited early stage researchers (ESRs) with the best possible international, interdisciplinary and inter-sectorial training. We shall accomplish this through both research and dedicated central training events to generate future European experts in the field of inflammation, both in academia and in companies. The ESRs will be able to identify the key challenges for research, model complex systems, identify new anti-inflammatory drugs and their targets, and communicate the results to a wide audience. These, entrepreneurial and innovative ESRs will be trained through both research projects and personalized training in transferable and soft skills.
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 955576.
This project is supported by region Occitanie Pyrénées – Méditerranée.